酞胺哌啶酮对耐顺铂人肺腺癌细胞系血管生成因子的影响
出处
《中华内科杂志》
CAS
CSCD
北大核心
2002年第7期481-483,共3页
Chinese Journal of Internal Medicine
基金
北京市自然科学基金资助项目 ( 7992 0 0 5)
北京科技新星计划 ( 14 8)
国家"九五"课题攻关项目( 96 90 6 0 1 2 3)
参考文献5
-
1Slodkowska J,Sikora J,Roszkowski-Sliz K,et al.Expression of vascular endothelial growth factor and basic fibroblast growth factor receptors in lung cancer[].Analytical and Quantitative Cytology.2000
-
2Ohta Y,Endo Y,Tanaka M,et al.Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer[].Clinical Cancer Research.1996
-
3Kerbel RS.Tumor angiogenesis: past, present and the near future[].Carcinogenesis.2000
-
4D′Amato RJ,Loughnan MS,Flynn E,et al.Thalidomide is an inhibitor of angiogenesis[].Proceedings of the National Academy of Sciences of the United States of America.1994
-
5Hideshima T,Chauhan D,Shima Y,et al.Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy[].Blood.2000
-
1王卉,江滨,刘开彦,邱镜滢,韩伟,陈欢,陆道培.酞胺哌啶酮治疗多发性骨髓瘤的临床观察[J].中华血液学杂志,2001,22(6):326-327. 被引量：6
-
2静雨.酞胺哌啶酮治疗骨髓瘤[J].国外医学情报,2001,22(5):36-37.
-
3田发青,李娟,唐玫琴,李举亨,成小慧,黄映彩,李惠卿.沙利度胺单药诱导急性单核细胞白血病完全缓解1例并文献复习[J].临床血液学杂志,2017,30(1):66-68.
-
4任洪军,杨静.酞胺哌啶酮治疗多发性骨髓瘤11例临床观察[J].承德医学院学报,2005,22(2):167-168.
-
5杨玮,张学进,赵毅,邓旻.反应停治疗多发性骨髓瘤8例疗效观察[J].浙江实用医学,2003,8(3):163-164.
-
6张瑾,杜华平,王一红,黄金文.酞胺哌啶酮联合美法仑、泼尼松治疗多发性骨髓瘤疗效观察[J].浙江医学,2004,26(7):542-544.
-
7董秀娟,陈蕾,吴艳,赛亚,马东燕,赵晓武.酞胺哌啶酮治疗多发性骨髓瘤12例临床观察[J].青岛医药卫生,2007,39(3):183-185. 被引量：1
-
8李鸽.酞胺哌啶酮联合化疗治疗多发性骨髓瘤的临床观察[J].浙江临床医学,2003,5(2):126-126.
-
9李瑞玲.酞胺哌啶酮治疗难治性多发性骨髓瘤的效果观察[J].中国实用神经疾病杂志,2009,12(20):58-59.
-
10GAO Song YANG Xue-jun ZHANG Wen-gao JI Yan-wei PAN Qiang.Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro[J].Chinese Medical Journal,2009(11):1260-1266. 被引量：16
